JP2002508362A5 - １−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体） - Google Patents
１−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体） Download PDFInfo
- Publication number
- JP2002508362A5 JP2002508362A5 JP2000539002A JP2000539002A JP2002508362A5 JP 2002508362 A5 JP2002508362 A5 JP 2002508362A5 JP 2000539002 A JP2000539002 A JP 2000539002A JP 2000539002 A JP2000539002 A JP 2000539002A JP 2002508362 A5 JP2002508362 A5 JP 2002508362A5
- Authority
- JP
- Japan
- Prior art keywords
- aminomethyl
- substituted
- cycloalkane derivative
- gabapentin analog
- gabapentin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapen Chemical class OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title 1
- 229960002870 gabapentin Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- -1 hydroxy, carboxy Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Description
【特許請求の範囲】
【請求項１】 下記式：
【化３４】
［式中、ｎは０〜２の整数であり；
ｍは０〜３の整数であり；
Ｒは下記：
【化３５】
から選択される複素環であり；
Ｒ1〜Ｒ14は相互に独立して水素または炭素原子１〜６個の直鎖または分枝鎖のアルキル、未置換かまたは置換されたベンジルまたはフェニルであり、その置換基はハロゲン、アルキル、アルコキシ、ヒドロキシ、カルボキシ、カルボアルコキシ、トリフルオロメチルおよびニトロから選択されるものであり；
Ａ′は下記：
【化３６】
｛式中、Ｚ1〜Ｚ4は相互に独立して水素およびメチルから選択され；
ｏは１〜４の整数であり；そして、
ｐは０〜２の整数である｝から選択される架橋環であるが、ただし、
式１においてｍが２でありそしてｎが１である場合はＲは−ＳＯ3Ｈではない］の化合物または製薬上許容しうるその塩。
【請求項１】 下記式：
【化３４】
ｍは０〜３の整数であり；
Ｒは下記：
【化３５】
Ｒ1〜Ｒ14は相互に独立して水素または炭素原子１〜６個の直鎖または分枝鎖のアルキル、未置換かまたは置換されたベンジルまたはフェニルであり、その置換基はハロゲン、アルキル、アルコキシ、ヒドロキシ、カルボキシ、カルボアルコキシ、トリフルオロメチルおよびニトロから選択されるものであり；
Ａ′は下記：
【化３６】
ｏは１〜４の整数であり；そして、
ｐは０〜２の整数である｝から選択される架橋環であるが、ただし、
式１においてｍが２でありそしてｎが１である場合はＲは−ＳＯ3Ｈではない］の化合物または製薬上許容しうるその塩。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6977397P | 1997-12-16 | 1997-12-16 | |
| US60/069,773 | 1997-12-16 | ||
| US10500598P | 1998-10-20 | 1998-10-20 | |
| US60/105,005 | 1998-10-20 | ||
| PCT/US1998/023918 WO1999031075A1 (en) | 1997-12-16 | 1998-11-10 | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002508362A JP2002508362A (ja) | 2002-03-19 |
| JP2002508362A5 true JP2002508362A5 (ja) | 2006-01-05 |
Family
ID=26750409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000539002A Pending JP2002508362A (ja) | 1997-12-16 | 1998-11-10 | １−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体）、その製造および神経学的疾患の治療におけるその使用 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6518289B1 (ja) |
| EP (2) | EP1047678B1 (ja) |
| JP (1) | JP2002508362A (ja) |
| KR (1) | KR20010033158A (ja) |
| CN (2) | CN1495160A (ja) |
| AT (1) | ATE275552T1 (ja) |
| AU (1) | AU765802B2 (ja) |
| BR (1) | BR9814286A (ja) |
| CA (1) | CA2304974C (ja) |
| DE (1) | DE69826151T2 (ja) |
| ES (1) | ES2227896T3 (ja) |
| HK (1) | HK1032966A1 (ja) |
| HU (1) | HUP0004439A3 (ja) |
| IL (1) | IL135313A0 (ja) |
| IS (1) | IS5435A (ja) |
| NO (2) | NO317252B1 (ja) |
| NZ (1) | NZ503963A (ja) |
| PL (1) | PL341291A1 (ja) |
| PT (1) | PT1047678E (ja) |
| SI (1) | SI1047678T1 (ja) |
| TR (1) | TR200001795T2 (ja) |
| WO (1) | WO1999031075A1 (ja) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2304967C (en) * | 1997-12-16 | 2005-06-14 | Warner-Lambert Company | 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| GB9901691D0 (en) | 1999-01-26 | 1999-03-17 | Cerebrus Ltd | Chemical compounds |
| YU37602A (sh) | 1999-12-01 | 2005-07-19 | Ucb S.A. | Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns |
| GB2362646A (en) * | 2000-05-26 | 2001-11-28 | Warner Lambert Co | Cyclic amino acid derivatives useful as pharmaceutical agents |
| GB0018272D0 (en) | 2000-07-25 | 2000-09-13 | Vernalis Research Limited | Chemical compounds IV |
| EP1361847A2 (en) | 2000-10-06 | 2003-11-19 | Xenoport, Inc. | Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| AU2002211863A1 (en) | 2000-10-06 | 2002-04-15 | Xenoport, Inc. | Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration |
| US6620829B2 (en) * | 2000-10-17 | 2003-09-16 | Warner-Lambert Company | Method of treating noninflammatory cartilage damage |
| GB2368579A (en) * | 2000-10-31 | 2002-05-08 | Parke Davis & Co Ltd | Azole pharmaceutical agents |
| CZ20032764A3 (cs) | 2001-04-19 | 2004-04-14 | Warner-Lambert Company | Fúzní bicyklické nebo tricyklické aminokyseliny |
| EP1412324A4 (en) | 2001-06-11 | 2004-09-29 | Xenoport Inc | AMINO ACID CONJUGATES THAT RESULT IN GABA ANALOGA LASTING SYSTEMIC CONCENTRATIONS |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| WO2002100347A2 (en) | 2001-06-11 | 2002-12-19 | Xenoport, Inc. | Prodrugs of gaba analogs, compositions and uses thereof |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| CN1625393A (zh) | 2002-01-31 | 2005-06-08 | 沃纳-兰伯特公司 | 治疗耳鸣的α2δ配体 |
| EP1485082A4 (en) | 2002-02-19 | 2009-12-30 | Xenoport Inc | PROCESS FOR THE SYNTHESIS OF PROMEDICAMENTS FROM 1-ACYL-ALKYL DERIVATIVES AND CORRESPONDING COMPOSITIONS |
| WO2003080588A1 (en) | 2002-03-20 | 2003-10-02 | Xenoport | Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof |
| WO2003099338A2 (en) | 2002-05-17 | 2003-12-04 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| JP2005534678A (ja) * | 2002-06-27 | 2005-11-17 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | 注意欠陥多動性障害の治療方法 |
| GB0219024D0 (en) * | 2002-08-15 | 2002-09-25 | Pfizer Ltd | Synergistic combinations |
| AU2003297927A1 (en) | 2002-12-11 | 2004-06-30 | Xenoport, Inc. | Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof |
| CA2451267A1 (en) | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
| ATE465725T1 (de) | 2002-12-13 | 2010-05-15 | Warner Lambert Co | Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege |
| MXPA05009504A (es) * | 2003-03-07 | 2005-10-18 | Warner Lambert Co | Derivados de (-aminoacidos sustituidos con tetrazol y oxadiazolona. |
| JP2006526017A (ja) * | 2003-05-14 | 2006-11-16 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
| EP1680125A1 (en) * | 2003-07-02 | 2006-07-19 | Warner-Lambert Company LLC | Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor |
| MXPA06002731A (es) | 2003-09-11 | 2006-06-05 | Xenoport Inc | Tratamiento y/o prevencion de incontinencia urinaria utilizando profarmacos de analogos de gaba. |
| ATE449633T1 (de) | 2003-09-12 | 2009-12-15 | Pfizer | Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern |
| BRPI0414481A (pt) | 2003-09-17 | 2006-11-14 | Xenoport Inc | métodos de tratamento ou de prevenção da sìndrome das pernas inquietas em um paciente e de melhoria do sono em um paciente com sìndrome das pernas inquietas, e, composição farmacêutica |
| KR101096480B1 (ko) | 2003-10-14 | 2011-12-20 | 제노포트 인코포레이티드 | 감마-아미노부티르산 유사체의 결정질 형태 |
| EP1691811B1 (en) | 2003-12-11 | 2014-07-23 | Sunovion Pharmaceuticals Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| US20050209319A1 (en) * | 2004-03-18 | 2005-09-22 | Xenoport, Inc. | Treatment of local pain |
| NZ554737A (en) | 2004-11-04 | 2011-04-29 | Xenoport Inc | Gabapentin prodrug sustained release oral dosage forms |
| EP1820502A1 (en) | 2006-02-10 | 2007-08-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising azolylcarbinol compounds |
| TW200806627A (en) * | 2006-04-11 | 2008-02-01 | Novartis Ag | Organic compounds |
| AR061728A1 (es) * | 2006-06-30 | 2008-09-17 | Pfizer Prod Inc | Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1 |
| US7727978B2 (en) | 2006-08-24 | 2010-06-01 | Bristol-Myers Squibb Company | Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| CA2664251A1 (en) | 2006-09-12 | 2008-03-20 | Cephalin Pharmaceuticals Inc. | Isovaline for treatment of pain |
| CN101600458A (zh) | 2006-12-22 | 2009-12-09 | 瑞蔻达蒂爱尔兰有限公司 | 采用α2δ配体和NSAID的下泌尿道疾病的联合治疗 |
| EP2124913A1 (en) * | 2006-12-22 | 2009-12-02 | Novartis AG | 1-aminomethyl- l- phenyl- cyclohexane derivatives as ddp-iv inhibitors |
| WO2008155619A2 (en) * | 2007-06-21 | 2008-12-24 | Pfizer Inc. | Preparation of optically-active cyclic amino acids |
| JP2010536852A (ja) * | 2007-08-23 | 2010-12-02 | ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニヴァーシティ | シナプス形成の調節 |
| US8119658B2 (en) | 2007-10-01 | 2012-02-21 | Bristol-Myers Squibb Company | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| WO2009094577A2 (en) | 2008-01-25 | 2009-07-30 | Xenoport, Inc. | Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
| EP2250148B1 (en) | 2008-01-25 | 2016-08-17 | XenoPort, Inc. | Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use |
| TWI380812B (zh) | 2008-01-25 | 2013-01-01 | Xenoport Inc | （３ｓ）-胺甲基-５-甲基己酸前藥之晶形及使用方法 |
| US20110092564A1 (en) * | 2008-02-26 | 2011-04-21 | Ernest Puil | Cyclic amino acids for the treatment of pain |
| EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
| JP2012505238A (ja) | 2008-10-08 | 2012-03-01 | カイフィア ファーマシューティカルズ， インコーポレイテッド | Ｇａｂａコンジュゲートおよびそれらの使用方法 |
| EP2353591A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
| EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
| EP2388005A1 (en) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| EP2415471A1 (en) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in opioid-induced hyperalgesia |
| EP2524694A1 (en) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in diabetes type-2 associated pain |
| US9066853B2 (en) | 2013-01-15 | 2015-06-30 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable fiber |
| CA2903000C (en) | 2013-01-28 | 2021-10-12 | Hector L. Lopez | Methods of improving tolerability, pharmacodynamics, and efficacy of .beta.-alanine and use therefor |
| TN2016000229A1 (en) | 2013-12-17 | 2017-10-06 | Esteve Labor Dr | Gabapentinoids and sigma receptor ligands combinations. |
| KR20160097366A (ko) | 2013-12-17 | 2016-08-17 | 라보라토리오스 델 드라. 에스테브.에스.에이. | 세로토닌-노르에피네프린 재흡수 억제제들(SNRIs) 및 시그마 리셉터 리간드들 조합 |
| AU2014364693B2 (en) * | 2013-12-18 | 2018-12-06 | Novassay Sa | Gamma-aminobutyric acid (GABA) analogues for the treatment of pain and other disorders |
| US9394237B2 (en) | 2014-02-03 | 2016-07-19 | Quadriga Biosciences, Inc. | β-substituted β-amino acids and analogs as chemotherapeutic agents |
| CN106132406B (zh) | 2014-02-03 | 2020-03-27 | 夸德里加生物科学公司 | 作为化疗剂的β-取代的γ-氨基酸和类似物 |
| EP3331851A1 (en) | 2015-08-03 | 2018-06-13 | Quadriga Biosciences, Inc. | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof |
| KR20210013081A (ko) | 2018-05-14 | 2021-02-03 | 엑스진 파마슈티컬 인크. | 나프록센 및 프레가발린의 1-(아실옥시)-알킬 카르바메이트 약물 복합체의 결정형 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6804065A (ja) * | 1968-03-22 | 1969-09-24 | ||
| BE789025A (fr) * | 1971-09-23 | 1973-03-20 | Allen & Hanburys Ltd | Nouvelles ethylene diamines substituees |
| US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DK427879A (da) * | 1978-10-13 | 1980-04-14 | Janssen Pharmaceutica Nv | (-arylcycloalkylmethyl)isothiocyanater. |
| DE3300774A1 (de) * | 1983-01-12 | 1984-07-12 | Hoechst Ag, 6230 Frankfurt | Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung |
| DE3327318C1 (de) * | 1983-07-29 | 1985-03-14 | Gödecke AG, 1000 Berlin | 1-Aminomethylcyclohexylmethan-sulfonsaeure,Verfahren zu deren Herstellung und deren Verwendung |
| US4755594A (en) * | 1986-01-31 | 1988-07-05 | Warner-Lambert Company | N6 -substituted adenosines |
| DE3634066A1 (de) * | 1986-10-07 | 1988-04-21 | Boehringer Mannheim Gmbh | Neue 5-alkylbenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel |
| US5015644A (en) * | 1987-06-02 | 1991-05-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
| US6197819B1 (en) | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
| FR2674522B1 (fr) * | 1991-03-26 | 1993-07-16 | Lipha | Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant. |
| FR2687402B1 (fr) * | 1992-02-14 | 1995-06-30 | Lipha | Nouveaux azaindoles, procedes de preparation et medicaments les contenant. |
| CA2123728A1 (en) * | 1993-05-21 | 1994-11-22 | Noriyoshi Sueda | Urea derivatives and their use as acat inhibitors |
| JPH07101929A (ja) * | 1993-10-01 | 1995-04-18 | Fujisawa Pharmaceut Co Ltd | 尿素誘導体およびその製造法 |
| GEP20012413B (en) * | 1996-03-14 | 2001-04-25 | Warner Lambert Co | Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents |
| IL125364A0 (en) * | 1996-03-14 | 1999-03-12 | Warner Lambert Co | Novel bridged cyclic amino acids and pharmaceutical compositions containing them |
| ATE311383T1 (de) * | 1996-08-22 | 2005-12-15 | Warner Lambert Co | Nicht-peptidische bombesin rezeptor antagonisten |
-
1998
- 1998-11-10 CN CNA2003101142270A patent/CN1495160A/zh active Pending
- 1998-11-10 PT PT98957745T patent/PT1047678E/pt unknown
- 1998-11-10 DE DE69826151T patent/DE69826151T2/de not_active Expired - Fee Related
- 1998-11-10 US US09/509,905 patent/US6518289B1/en not_active Expired - Fee Related
- 1998-11-10 EP EP98957745A patent/EP1047678B1/en not_active Expired - Lifetime
- 1998-11-10 IL IL13531398A patent/IL135313A0/xx unknown
- 1998-11-10 SI SI9830690T patent/SI1047678T1/xx unknown
- 1998-11-10 JP JP2000539002A patent/JP2002508362A/ja active Pending
- 1998-11-10 EP EP04006036A patent/EP1475371A1/en not_active Withdrawn
- 1998-11-10 CN CN98811481XA patent/CN1131855C/zh not_active Expired - Fee Related
- 1998-11-10 CA CA002304974A patent/CA2304974C/en not_active Expired - Fee Related
- 1998-11-10 AU AU13929/99A patent/AU765802B2/en not_active Ceased
- 1998-11-10 TR TR2000/01795T patent/TR200001795T2/xx unknown
- 1998-11-10 PL PL98341291A patent/PL341291A1/xx unknown
- 1998-11-10 NZ NZ503963A patent/NZ503963A/xx unknown
- 1998-11-10 KR KR1020007006535A patent/KR20010033158A/ko not_active Application Discontinuation
- 1998-11-10 WO PCT/US1998/023918 patent/WO1999031075A1/en not_active Application Discontinuation
- 1998-11-10 HU HU0004439A patent/HUP0004439A3/hu unknown
- 1998-11-10 ES ES98957745T patent/ES2227896T3/es not_active Expired - Lifetime
- 1998-11-10 AT AT98957745T patent/ATE275552T1/de not_active IP Right Cessation
- 1998-11-10 BR BR9814286-0A patent/BR9814286A/pt not_active Application Discontinuation
-
2000
- 2000-04-07 IS IS5435A patent/IS5435A/is unknown
- 2000-06-14 NO NO20003039A patent/NO317252B1/no not_active IP Right Cessation
-
2001
- 2001-05-23 HK HK01103570A patent/HK1032966A1/xx not_active IP Right Cessation
-
2004
- 2004-03-17 NO NO20041112A patent/NO20041112L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002508362A5 (ja) | １−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体） | |
| JP2002508352A5 (ja) | ４(３)置換−４(３)−アミノメチル−（チオ）ピラン又はピペリジン誘導体（＝ガバペンチン類似体） | |
| JP2002543183A5 (ja) | ||
| JP2003528918A5 (ja) | ||
| HUP0004439A2 (hu) | 1-Helyettesített-1-amino-metil-cikloalkán-származékok (gabapentin analógok), a vegyületek előállítása és neurológiai rendellenességek kezelésében való alkalmazása | |
| CY1108586T1 (el) | Υποκαταστημενα παραγωγα φαινυλοπροπιονικου οξεος | |
| JP2001519410A5 (ja) | ||
| JP2002518502A5 (ja) | ||
| JP2002502874A5 (ja) | ||
| CA2110454A1 (en) | 1,5,7-trisubstituted indoline compounds for the treatment of dysuria | |
| JP2002513793A5 (ja) | ||
| EP1008592A3 (en) | Cyclic amide derivatives which inhibit cathepsin K | |
| JP2002526516A5 (ja) | ||
| JP2001525394A5 (ja) | ||
| JP2002506864A5 (ja) | ||
| JP2003503449A5 (ja) | ||
| JP2002535387A5 (ja) | ||
| CA2382247A1 (en) | Azaindoles having serotonin receptor affinity | |
| JP2002526526A5 (ja) | ||
| JP2002520286A5 (ja) | ||
| JP2002522386A5 (ja) | ||
| CA2220759A1 (en) | 1,4-benzodioxin derivatives | |
| JP2002510667A5 (ja) | ||
| CA2196769A1 (en) | Benzimidazole derivatives having dopaminergic activity | |
| JP2001519413A5 (ja) |